Skip to main content
Top
Published in: BMC Primary Care 1/2020

Open Access 01-12-2020 | Insulins | Research article

Physician related barriers towards insulin therapy at primary care centres in Trinidad: a cross-sectional study

Author: Shastri Motilal

Published in: BMC Primary Care | Issue 1/2020

Login to get access

Abstract

Background

Physician related factors with respect to insulin therapy can contribute to diabetes mellitus (DM) mismanagement. Patient related factors have been previously explored in a Trinidad survey. The main objective of this study was to explore primary care physicians’ (PCPs) related barriers towards insulin therapy.

Methods

A cross-sectional study on a convenience sample of PCPs in the public primary care system was done using an online survey.

Results

Of the 170 PCPs contacted, 75 (44%) responded. There were 47 females (62.7%) and 28 males (37.3%) with a mean age of 35.9 yrs. Nearly 40% of physicians admitted that the education given to patients was inadequate to allow initiation of insulin therapy. Half the respondents admitted to insufficient consultation times and inadequate appointment frequency to allow for intensification of insulin therapy. Forty percent of PCPs admitted that HbA1c results were unavailable to guide their management decisions. Only 6.7% of physicians said they had access to rapid acting insulin, while 5.3% said they had access to insulin pens.

Conclusion

PCPs in Trinidad treating diabetes at the public primary care clinics face several barriers in administering proper insulin therapy. Addressing these factors can improve glycemic control in this population.
Appendix
Available only for authorised users
Literature
2.
go back to reference Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers. J Glob Health. 2017;7(2):020410.CrossRef Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers. J Glob Health. 2017;7(2):020410.CrossRef
5.
go back to reference Apparico N, Clerk N, Henry G, Seale J, Sealy R, Ward S, et al. How well controlled are our type 2 diabetic patients in 2002? An observational study in north and Central Trinidad. Diabetes Res Clin Pract. 2007;75(3):301–5.CrossRef Apparico N, Clerk N, Henry G, Seale J, Sealy R, Ward S, et al. How well controlled are our type 2 diabetic patients in 2002? An observational study in north and Central Trinidad. Diabetes Res Clin Pract. 2007;75(3):301–5.CrossRef
6.
go back to reference Morren JA, Baboolal N, Davis GK, McRae A. Assessment of treatment goals attained by patients according to guidelines for diabetes management in primary care centres in North Trinidad. Qual Prim Care. 2010;18(5):335–43.PubMed Morren JA, Baboolal N, Davis GK, McRae A. Assessment of treatment goals attained by patients according to guidelines for diabetes management in primary care centres in North Trinidad. Qual Prim Care. 2010;18(5):335–43.PubMed
7.
go back to reference Introduction: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S1–2. Introduction: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S1–2.
8.
go back to reference Bobb A, Gale D, Manmohan S, Mohammed A, Seetahal F, Small P, et al. The impact of the chronic disease assistance plan (CDAP) on the control of type 2 diabetes in Trinidad. Diabetes Res Clin Pract. 2008;80(3):360–4.CrossRef Bobb A, Gale D, Manmohan S, Mohammed A, Seetahal F, Small P, et al. The impact of the chronic disease assistance plan (CDAP) on the control of type 2 diabetes in Trinidad. Diabetes Res Clin Pract. 2008;80(3):360–4.CrossRef
9.
go back to reference Khan H, Lasker SS, Chowdhury TA. Exploring reasons for very poor glycaemic control in patients with type 2 diabetes. Prim Care Diabetes. 2011;5(4):251–5.CrossRef Khan H, Lasker SS, Chowdhury TA. Exploring reasons for very poor glycaemic control in patients with type 2 diabetes. Prim Care Diabetes. 2011;5(4):251–5.CrossRef
10.
go back to reference Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes. 2017;11(1):3–12.CrossRef Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes. 2017;11(1):3–12.CrossRef
11.
go back to reference Russell-Jones D, Pouwer F, Khunti K. Identification of barriers to insulin therapy and approaches to overcoming them. Diabetes Obes Metab. 2018;20(3):488–96.CrossRef Russell-Jones D, Pouwer F, Khunti K. Identification of barriers to insulin therapy and approaches to overcoming them. Diabetes Obes Metab. 2018;20(3):488–96.CrossRef
12.
go back to reference Bin rsheed A, Chenoweth I. Barriers that practitioners face when initiating insulin therapy in general practice settings and how they can be overcome. World J Diabetes 2017;8(1):28–39. Bin rsheed A, Chenoweth I. Barriers that practitioners face when initiating insulin therapy in general practice settings and how they can be overcome. World J Diabetes 2017;8(1):28–39.
13.
go back to reference Perreault L, Vincent L, Neumiller JJ, Santos-Cavaiola T. Initiation and titration of basal insulin in primary care: barriers and practical solutions. J Am Board Fam Med JABFM. 2019;32(3):431–47.CrossRef Perreault L, Vincent L, Neumiller JJ, Santos-Cavaiola T. Initiation and titration of basal insulin in primary care: barriers and practical solutions. J Am Board Fam Med JABFM. 2019;32(3):431–47.CrossRef
14.
go back to reference Campbell MD, Babic D, Bolcina U, Smirčić-Duvnjak L, Tankova T, Mitrakou A, et al. High level of clinical inertia in insulin initiation in type 2 diabetes across central and South-Eastern Europe: insights from SITIP study. Acta Diabetol. 2019;56(9):1045–9.CrossRef Campbell MD, Babic D, Bolcina U, Smirčić-Duvnjak L, Tankova T, Mitrakou A, et al. High level of clinical inertia in insulin initiation in type 2 diabetes across central and South-Eastern Europe: insights from SITIP study. Acta Diabetol. 2019;56(9):1045–9.CrossRef
15.
go back to reference Beneby N, Isaacs C, King L, Leon F, Taylor A, et al. Knowledge, Attitudes and Perceptions of Patients towards Insulin Therapy at Primary Care Centers in Trinidad. J Community Med Public Health Care. 2015;2:004. Beneby N, Isaacs C, King L, Leon F, Taylor A, et al. Knowledge, Attitudes and Perceptions of Patients towards Insulin Therapy at Primary Care Centers in Trinidad. J Community Med Public Health Care. 2015;2:004.
18.
go back to reference Polinski JM, Smith BF, Curtis BH, Seeger JD, Choudhry NK, Connolly JG, et al. Barriers to insulin progression among patients with type 2 diabetes: a systematic review. Diabetes Educ. 2013;39(1):53–65.CrossRef Polinski JM, Smith BF, Curtis BH, Seeger JD, Choudhry NK, Connolly JG, et al. Barriers to insulin progression among patients with type 2 diabetes: a systematic review. Diabetes Educ. 2013;39(1):53–65.CrossRef
19.
go back to reference Ishii H, Iwamoto Y, Tajima N. An exploration of barriers to insulin initiation for physicians in Japan: findings from the diabetes attitudes, wishes and needs (DAWN) JAPAN study. PLoS One. 2012;7(6):e36361.CrossRef Ishii H, Iwamoto Y, Tajima N. An exploration of barriers to insulin initiation for physicians in Japan: findings from the diabetes attitudes, wishes and needs (DAWN) JAPAN study. PLoS One. 2012;7(6):e36361.CrossRef
20.
go back to reference Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger P-M. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study. Diabet Med. 2012;29(5):682–9.CrossRef Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger P-M. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study. Diabet Med. 2012;29(5):682–9.CrossRef
21.
go back to reference Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract. 2008;62(6):860–8.CrossRef Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clin Pract. 2008;62(6):860–8.CrossRef
22.
go back to reference Ates E, Set T, Saglam Z, Tekin N, Karatas Eray I, Yavuz E, et al. Insulin initiation status of primary care physicians in Turkey, barriers to insulin initiation and knowledge levels about insulin therapy: a multicenter cross-sectional study. Prim Care Diabetes. 2017;11(5):430–6.CrossRef Ates E, Set T, Saglam Z, Tekin N, Karatas Eray I, Yavuz E, et al. Insulin initiation status of primary care physicians in Turkey, barriers to insulin initiation and knowledge levels about insulin therapy: a multicenter cross-sectional study. Prim Care Diabetes. 2017;11(5):430–6.CrossRef
23.
go back to reference Taylor CG, Taylor G, Atherley A, Hambleton I, Unwin N, Adams OP. Barbados insulin matters (BIM) study: perceptions on insulin initiation by primary care doctors in the Caribbean island of Barbados. Prim Care Diabetes. 2017;11(2):140–7.CrossRef Taylor CG, Taylor G, Atherley A, Hambleton I, Unwin N, Adams OP. Barbados insulin matters (BIM) study: perceptions on insulin initiation by primary care doctors in the Caribbean island of Barbados. Prim Care Diabetes. 2017;11(2):140–7.CrossRef
24.
go back to reference Chadee A, Blackhouse G, Goeree R. Point-of-care hemoglobin A1c testing: a budget impact analysis. Ont Health Technol Assess Ser. 2014;14(9):1–23.PubMedPubMedCentral Chadee A, Blackhouse G, Goeree R. Point-of-care hemoglobin A1c testing: a budget impact analysis. Ont Health Technol Assess Ser. 2014;14(9):1–23.PubMedPubMedCentral
25.
go back to reference Motta LA, Shephard MDS, Brink J, Lawson S, Rheeder P. Point-of-care testing improves diabetes management in a primary care clinic in South Africa. Prim Care Diabetes. 2017;11(3):248–53.CrossRef Motta LA, Shephard MDS, Brink J, Lawson S, Rheeder P. Point-of-care testing improves diabetes management in a primary care clinic in South Africa. Prim Care Diabetes. 2017;11(3):248–53.CrossRef
26.
go back to reference John MN, Kreider KE, Thompson JA, Pereira K. Implementation of A1C point-of-care testing: serving under-resourced adults with type 2 diabetes in a public health department. Clin Diabetes Publ Am Diabetes Assoc. 2019;37(3):242–9.CrossRef John MN, Kreider KE, Thompson JA, Pereira K. Implementation of A1C point-of-care testing: serving under-resourced adults with type 2 diabetes in a public health department. Clin Diabetes Publ Am Diabetes Assoc. 2019;37(3):242–9.CrossRef
28.
go back to reference Barnes CS, Ziemer DC, Miller CD, Doyle JP, Watkins C, Cook CB, et al. Little time for diabetes management in the primary care setting. Diabetes Educ. 2004;30(1):126–35.CrossRef Barnes CS, Ziemer DC, Miller CD, Doyle JP, Watkins C, Cook CB, et al. Little time for diabetes management in the primary care setting. Diabetes Educ. 2004;30(1):126–35.CrossRef
29.
go back to reference Østbye T, Yarnall KSH, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005 Jun;3(3):209–14.CrossRef Østbye T, Yarnall KSH, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005 Jun;3(3):209–14.CrossRef
30.
go back to reference Angstman KB, Horn JL, Bernard ME, Kresin MM, Klavetter EW, Maxson J, et al. Family medicine panel size with care teams: impact on quality. J Am Board Fam Med JABFM. 2016 Aug;29(4):444–51.CrossRef Angstman KB, Horn JL, Bernard ME, Kresin MM, Klavetter EW, Maxson J, et al. Family medicine panel size with care teams: impact on quality. J Am Board Fam Med JABFM. 2016 Aug;29(4):444–51.CrossRef
31.
go back to reference Babwah T. Improving glycaemic control in patients attending a Trinidad health Centre: a three-year quality improvement project. Qual Prim Care. 2011;19(5):335–9.PubMed Babwah T. Improving glycaemic control in patients attending a Trinidad health Centre: a three-year quality improvement project. Qual Prim Care. 2011;19(5):335–9.PubMed
33.
go back to reference Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT. Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review. Diabetes Metab. 2011 Jun;37(3):190–200.CrossRef Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT. Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review. Diabetes Metab. 2011 Jun;37(3):190–200.CrossRef
34.
go back to reference Wojciechowski P, Niemczyk-Szechowska P, Olewińska E, Jaros P, Mierzejewska B, Skarżyńska-Duk J, et al. Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. Pol Arch Med Wewn. 2015;125(3):141–51.PubMed Wojciechowski P, Niemczyk-Szechowska P, Olewińska E, Jaros P, Mierzejewska B, Skarżyńska-Duk J, et al. Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. Pol Arch Med Wewn. 2015;125(3):141–51.PubMed
35.
go back to reference Chapman TM, Noble S, Goa KL. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus. Drugs. 2002;62(13):1945–81.CrossRef Chapman TM, Noble S, Goa KL. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus. Drugs. 2002;62(13):1945–81.CrossRef
36.
go back to reference Lasalvia P, Barahona-Correa JE, Romero-Alvernia DM, Gil-Tamayo S, Castañeda-Cardona C, Bayona JG, et al. Pen devices for insulin self-administration compared with needle and vial: systematic review of the literature and meta-analysis. J Diabetes Sci Technol. 2016;10(4):959–66.CrossRef Lasalvia P, Barahona-Correa JE, Romero-Alvernia DM, Gil-Tamayo S, Castañeda-Cardona C, Bayona JG, et al. Pen devices for insulin self-administration compared with needle and vial: systematic review of the literature and meta-analysis. J Diabetes Sci Technol. 2016;10(4):959–66.CrossRef
37.
go back to reference Grabner M, Chu J, Raparla S, Quimbo R, Zhou S, Conoshenti J. Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial. Postgrad Med. 2013 May;125(3):204–13.CrossRef Grabner M, Chu J, Raparla S, Quimbo R, Zhou S, Conoshenti J. Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial. Postgrad Med. 2013 May;125(3):204–13.CrossRef
38.
go back to reference Cuddihy RM, Borgman SK. Considerations for diabetes: treatment with insulin pen devices. Am J Ther. 2013 Dec;20(6):694–702.CrossRef Cuddihy RM, Borgman SK. Considerations for diabetes: treatment with insulin pen devices. Am J Ther. 2013 Dec;20(6):694–702.CrossRef
39.
go back to reference American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S77–88.CrossRef American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S77–88.CrossRef
40.
go back to reference Nulty DD. The adequacy of response rates to online and paper surveys: what can be done? Assess Eval High Educ. 2008;33(3):301–14.CrossRef Nulty DD. The adequacy of response rates to online and paper surveys: what can be done? Assess Eval High Educ. 2008;33(3):301–14.CrossRef
Metadata
Title
Physician related barriers towards insulin therapy at primary care centres in Trinidad: a cross-sectional study
Author
Shastri Motilal
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2020
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-020-01271-1

Other articles of this Issue 1/2020

BMC Primary Care 1/2020 Go to the issue